Marker Therapeutics Inc

NASDAQ:MRKR

0.93

+0.03 (+3.30%)

7:58:26 PM EDT: $0.90 -0.02 (-2.29%)

Market Cap (Intraday)	12.37M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.72 Million
Adjusted EPS	-$0.36

See more estimates

10-Day MA	$1.07
50-Day MA	$1.40
200-Day MA	$1.87

See more pivots

Marker Therapeutics Inc Stock, NASDAQ:MRKR

2450 Holcombe Boulevard, Suite BCM-A, MS: BCM251, Houston, Texas 77021

United States of America

Phone: +1.713.400.6400

Number of Employees: 8

http://www.markertherapeutics.com

Description

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.